The person that posted this thread (Ashley Sumrall who is a neurooncologist - https://www.linkedin.com/in/ashley-sumrall-md-facp-0527b144/) seems to be fascinated about the information that we all know from the abstracts and announcements regarding specificity, safety, and it's early efficacy readings
---
Prior to the weekend, we did not even know if chlorotoxin, would get a mention by Christine. Now it turns out the feature presentation at SNO AGM 2021, was our drug.
Agree, with above Dlfg1234....however the SP was sold off on the data. Who might know best, Ashley, or the other neurosurgeons, who posted on twitter - or those last week, that pushed the EV for the company down to US$60M - ridiculous.
-------------------------
Ashley Love Sumrall, MD, FACP @AshleySumrallMD CLTXCART car therapy #CAR#chlorotoxin on trial @cityofhope . Safety has been shown
-----------------------
Maciej M Mrugala, MD, PhD, MPH
@MrugalaMaciej
Congratulations to Dr. Brown @cityofhope for her work on CART cells in glioma! The keynote lecture #SNO2021@NeuroOnctoday gives us all hope that this technology may help us beat malignant glioma #GBM
--------------------------------------------------
CHM Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)